BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Modo M, Kolosnjaj-Tabi J, Nicholls F, Ling W, Wilhelm C, Debarge O, Gazeau F, Clement O. Considerations for the clinical use of contrast agents for cellular MRI in regenerative medicine. Contrast Media Mol Imaging 2013;8:439-55. [PMID: 24375900 DOI: 10.1002/cmmi.1547] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
Number Citing Articles
1 Wiart M, Tavakoli C, Hubert V, Hristovska I, Dumot C, Parola S, Lerouge F, Chauveau F, Canet-soulas E, Pascual O, Cormode DP, Brun E, Elleaume H. Use of metal-based contrast agents for in vivo MR and CT imaging of phagocytic cells in neurological pathologies. Journal of Neuroscience Methods 2023;383:109729. [DOI: 10.1016/j.jneumeth.2022.109729] [Reference Citation Analysis]
2 Zagalo DM, Sousa J, Simões S. Quality by Design (QbD) Approach in Marketing Authorization Procedures of Non-Biological Complex Drugs: A Critical Evaluation. Eur J Pharm Biopharm 2022:S0939-6411(22)00151-5. [PMID: 35908664 DOI: 10.1016/j.ejpb.2022.07.014] [Reference Citation Analysis]
3 Modo M, Ghuman H, Azar R, Krafty R, Badylak SF, Hitchens TK. Mapping the acute time course of immune cell infiltration into an ECM hydrogel in a rat model of stroke using 19F MRI. Biomaterials 2022;282:121386. [DOI: 10.1016/j.biomaterials.2022.121386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
4 Ali F. Regulatory perspectives of nanomaterials for theranostic application. Nanotheranostics for Treatment and Diagnosis of Infectious Diseases 2022. [DOI: 10.1016/b978-0-323-91201-3.00008-6] [Reference Citation Analysis]
5 Ezealigo BN, Ezealigo US, Ighodalo KI, Ezema FI. Iron oxide nanoparticles: current and future applications in nanomedicine. Fundamentals and Industrial Applications of Magnetic Nanoparticles 2022. [DOI: 10.1016/b978-0-12-822819-7.00011-9] [Reference Citation Analysis]
6 Farinha P, Coelho JMP, Reis CP, Gaspar MM. A Comprehensive Updated Review on Magnetic Nanoparticles in Diagnostics. Nanomaterials (Basel) 2021;11:3432. [PMID: 34947781 DOI: 10.3390/nano11123432] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
7 Rankin-Turner S, Vader P, O'Driscoll L, Giebel B, Heaney LM, Davies OG. A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos. Adv Drug Deliv Rev 2021;173:479-91. [PMID: 33862168 DOI: 10.1016/j.addr.2021.04.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 25.0] [Reference Citation Analysis]
8 Mapanao AK, Voliani V. Three-dimensional tumor models: Promoting breakthroughs in nanotheranostics translational research. Applied Materials Today 2020;19:100552. [DOI: 10.1016/j.apmt.2019.100552] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
9 Cuccione E, Chhour P, Si-Mohamed S, Dumot C, Kim J, Hubert V, Da Silva CC, Vandamme M, Chereul E, Balegamire J, Chevalier Y, Berthezène Y, Boussel L, Douek P, Cormode DP, Wiart M. Multicolor spectral photon counting CT monitors and quantifies therapeutic cells and their encapsulating scaffold in a model of brain damage. Nanotheranostics 2020;4:129-41. [PMID: 32483519 DOI: 10.7150/ntno.45354] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
10 Foulkes R, Man E, Thind J, Yeung S, Joy A, Hoskins C. The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives. Biomater Sci 2020;8:4653-64. [DOI: 10.1039/d0bm00558d] [Cited by in Crossref: 63] [Cited by in F6Publishing: 72] [Article Influence: 31.5] [Reference Citation Analysis]
11 Nuzhina JV, Shtil AA, Prilepskii AY, Vinogradov VV. Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines. Journal of Drug Delivery Science and Technology 2019;54:101282. [DOI: 10.1016/j.jddst.2019.101282] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
12 Barrow M, Taylor A, Fuentes-Caparrós AM, Sharkey J, Daniels LM, Mandal P, Park BK, Murray P, Rosseinsky MJ, Adams DJ. SPIONs for cell labelling and tracking using MRI: magnetite or maghemite? Biomater Sci 2017;6:101-6. [PMID: 29188240 DOI: 10.1039/c7bm00515f] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
13 Teston E, Maldiney T, Marangon I, Volatron J, Lalatonne Y, Motte L, Boisson-Vidal C, Autret G, Clément O, Scherman D, Gazeau F, Richard C. Nanohybrids with Magnetic and Persistent Luminescence Properties for Cell Labeling, Tracking, In Vivo Real-Time Imaging, and Magnetic Vectorization. Small 2018;14:e1800020. [PMID: 29542273 DOI: 10.1002/smll.201800020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
14 Lamanna JJ, Gutierrez J, Espinosa JR, Wagner J, Urquia LN, Moreton C, Victor Hurtig C, Tora M, Kirk AD, Federici T, Boulis NM. Peripheral blood detection of systemic graft-specific xeno-antibodies following transplantation of human neural progenitor cells into the porcine spinal cord. J Clin Neurosci 2018;48:173-80. [PMID: 29089163 DOI: 10.1016/j.jocn.2017.10.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
15 Zhang M, Liu X, Huang J, Wang L, Shen H, Luo Y, Li Z, Zhang H, Deng Z, Zhang Z. Ultrasmall graphene oxide based T1 MRI contrast agent for in vitro and in vivo labeling of human mesenchymal stem cells. Nanomedicine 2018;14:2475-83. [PMID: 28552648 DOI: 10.1016/j.nano.2017.03.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
16 Kolosnjaj-tabi J, Volatron J, Gazeau F. Basic Principles of In Vivo Distribution, Toxicity, and Degradation of Prospective Inorganic Nanoparticles for Imaging. Design and Applications of Nanoparticles in Biomedical Imaging 2017. [DOI: 10.1007/978-3-319-42169-8_2] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
17 Bulte JWM, Modo MMJ. Nanoparticles as a Technology Platform for Biomedical Imaging. Design and Applications of Nanoparticles in Biomedical Imaging 2017. [DOI: 10.1007/978-3-319-42169-8_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
18 Chhour P, Kim J, Benardo B, Tovar A, Mian S, Litt HI, Ferrari VA, Cormode DP. Effect of Gold Nanoparticle Size and Coating on Labeling Monocytes for CT Tracking. Bioconjug Chem 2017;28:260-9. [PMID: 28095688 DOI: 10.1021/acs.bioconjchem.6b00566] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]
19 Nicholls FJ, Liu JR, Modo M. A Comparison of Exogenous Labels for the Histological Identification of Transplanted Neural Stem Cells. Cell Transplant. 2017;26:625-645. [PMID: 27938486 DOI: 10.3727/096368916X693680] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Jin T, Nicholls FJ, Crum WR, Ghuman H, Badylak SF, Modo M. Diamagnetic chemical exchange saturation transfer (diaCEST) affords magnetic resonance imaging of extracellular matrix hydrogel implantation in a rat model of stroke. Biomaterials 2017;113:176-90. [PMID: 27816001 DOI: 10.1016/j.biomaterials.2016.10.043] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 3.8] [Reference Citation Analysis]
21 Modo M. Gaining Mechanistic Insights into Cell Therapy Using Magnetic Resonance Imaging. Curr Stem Cell Rep 2016;2:221-227. [DOI: 10.1007/s40778-016-0059-z] [Reference Citation Analysis]
22 Lamanna JJ, Gutierrez J, Urquia LN, Hurtig CV, Amador E, Grin N, Svendsen CN, Federici T, Oshinski JN, Boulis NM. Ferumoxytol Labeling of Human Neural Progenitor Cells for Diagnostic Cellular Tracking in the Porcine Spinal Cord with Magnetic Resonance Imaging. Stem Cells Transl Med 2017;6:139-50. [PMID: 28170192 DOI: 10.5966/sctm.2015-0422] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
23 Barrow M, Taylor A, García Carrión J, Mandal P, Park BK, Poptani H, Murray P, Rosseinsky MJ, Adams DJ. Co-precipitation of DEAE-dextran coated SPIONs: how synthesis conditions affect particle properties, stem cell labelling and MR contrast. Contrast Media Mol Imaging 2016;11:362-70. [PMID: 27358113 DOI: 10.1002/cmmi.1700] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
24 Barrow M, Taylor A, Murray P, Rosseinsky MJ, Adams DJ. Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI. Chem Soc Rev 2015;44:6733-48. [PMID: 26169237 DOI: 10.1039/c5cs00331h] [Cited by in Crossref: 137] [Cited by in F6Publishing: 145] [Article Influence: 22.8] [Reference Citation Analysis]
25 Silva AKA, Espinosa A, Kolosnjaj‐tabi J, Wilhelm C, Gazeau F. Medical Applications of Iron Oxide Nanoparticles. In: Faivre D, editor. Iron Oxides. Wiley; 2016. pp. 425-72. [DOI: 10.1002/9783527691395.ch18] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
26 Charlton JR, Pearl VM, Denotti AR, Lee JB, Swaminathan S, Scindia YM, Charlton NP, Baldelomar EJ, Beeman SC, Bennett KM. Biocompatibility of ferritin-based nanoparticles as targeted MRI contrast agents. Nanomedicine 2016;12:1735-45. [PMID: 27071333 DOI: 10.1016/j.nano.2016.03.007] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
27 Nicholls FJ, Rotz MW, Ghuman H, MacRenaris KW, Meade TJ, Modo M. DNA-gadolinium-gold nanoparticles for in vivo T1 MR imaging of transplanted human neural stem cells. Biomaterials 2016;77:291-306. [PMID: 26615367 DOI: 10.1016/j.biomaterials.2015.11.021] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 9.9] [Reference Citation Analysis]
28 Nicholls FJ, Ling W, Ferrauto G, Aime S, Modo M. Simultaneous MR imaging for tissue engineering in a rat model of stroke. Sci Rep 2015;5:14597. [PMID: 26419200 DOI: 10.1038/srep14597] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
29 Naumova AV, Modo M, Moore A, Murry CE, Frank JA. Clinical imaging in regenerative medicine. Nat Biotechnol 2014;32:804-18. [PMID: 25093889 DOI: 10.1038/nbt.2993] [Cited by in Crossref: 167] [Cited by in F6Publishing: 178] [Article Influence: 23.9] [Reference Citation Analysis]
30 Palma SICJ, Rodrigues CAV, Carvalho A, Morales MDP, Freitas F, Fernandes AR, Cabral JMS, Roque ACA. A value-added exopolysaccharide as a coating agent for MRI nanoprobes. Nanoscale 2015;7:14272-83. [DOI: 10.1039/c5nr01979f] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
31 Modo M, Braga R, Ray HL. In Vivo Imaging of Transplanted Cells and Biomaterials. Stem Cell Biology and Tissue Engineering in Dental Sciences 2015. [DOI: 10.1016/b978-0-12-397157-9.00069-2] [Reference Citation Analysis]
32 Bennett KM, Jo J, Cabral H, Bakalova R, Aoki I. MR imaging techniques for nano-pathophysiology and theranostics. Adv Drug Deliv Rev 2014;74:75-94. [PMID: 24787226 DOI: 10.1016/j.addr.2014.04.007] [Cited by in Crossref: 50] [Cited by in F6Publishing: 54] [Article Influence: 6.3] [Reference Citation Analysis]
33 Shapiro EM. Biodegradable, polymer encapsulated, metal oxide particles for MRI-based cell tracking. Magn Reson Med 2015;73:376-89. [PMID: 24753150 DOI: 10.1002/mrm.25263] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]